XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash $ 6,690 $ 10,278
Trade accounts receivable, net of allowance for expected credit losses of $296 and $300, respectively 31,055 31,761
Inventories, net 41,392 42,215
Prepaid expenses and other current assets 4,650 5,949
Total current assets 83,787 90,203
Property, plant and equipment, net 20,281 21,117
Goodwill 37,510 37,571
Other intangible assets, net 14,646 15,107
Deferred income taxes, net 9,088 10,567
Other noncurrent assets 4,505 3,711
Total assets 169,817 178,276
Current liabilities:    
Accounts payable 9,691 11,336
Current portion of long-term debt 2,000 2,000
Accrued compensation and related benefits 2,312 3,115
Accrued expenses and other current liabilities 6,570 7,279
Total current liabilities 20,573 23,730
Long-term debt 9,978 23,624
Deferred income taxes 1,642 1,714
Other noncurrent liabilities 4,279 3,781
Total liabilities 36,472 52,849
Commitments and Contingencies  
Stockholders’ equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 21,059,461 shares at June 30, 2024 and 20,783,607 shares at December 31, 2023; outstanding – 16,623,347 shares at June 30, 2024 and 16,347,493 shares at December 31, 2023 2,106 2,078
Capital in excess of par value 191,388 189,160
Accumulated deficit (34,894) (40,754)
Accumulated other comprehensive loss (3,895) (3,660)
Treasury stock - at cost; 4,436,114 shares at June 30, 2024 and 4,436,114 shares at December 31, 2023 (21,492) (21,492)
Total Ultralife Corporation equity 133,213 125,332
Non-controlling interest 132 95
Total stockholders’ equity 133,345 125,427
Total liabilities and stockholders’ equity $ 169,817 $ 178,276